HPV vaccination
HPV vaccination is a preventive immunization against infection with oncogenic and other clinically important types of human papillomavirus (HPV), a human papilloma virus.
HPV vaccination is a preventive immunization against infection with oncogenic and other clinically important types of human papillomavirus (HPV), a human papilloma virus. The vaccine stimulates type-specific adaptive immune responses that can prevent HPV infection and thereby reduce the risk of HPV-associated disease, including cervix uterine cancer and oropharyngeal cancer. It is intended to prevent new infections rather than treat established HPV infection, HPV-related lesions, or cancer; routine screening remains important where recommended.
HPV vaccination programmes commonly focus on adolescents, while some policies also provide access to adults aged 27–45 years and other populations. Their public-health impact depends on vaccine uptake and coverage, timely clinician recommendations, access, health literacy, and acceptance by parents and individuals. Vaccine hesitancy, socioeconomic inequalities, and differences in national policy can limit vaccination rates, whereas culturally tailored education and digital interventions may improve knowledge, intentions, and uptake.
Where the papers sit
10 papers from the last 6 months study HPV vaccination directly · updated from PubMed 9 Oct 2026
Study type 1 clinical trial · 5 observational · 4 human data
Themes 3 themes · 1 new direction
-
HPV Vaccine Hesitancy and Education
HPV vaccine acceptance is being approached through parental knowledge, culturally tailored education and targeted behavioral interventions. Barriers recur around limited awareness, uncertainty about vaccine benefits and concerns affecting adolescent vaccination decisions. Mobile tools such as HPVVaxFacts aim to make accurate information more accessible, while studies in women and university students examine willingness and intention as intermediate outcomes. Whether improved knowledge produces durable vaccination behavior remains unresolved.
4 papers · 40%
-
Adult HPV Vaccine Uptake
Adult HPV vaccination remains limited in the 27–45 age group, despite its potential role in preventing oropharyngeal cancer. Uptake work increasingly emphasizes clinician recommendations as a modifiable influence. Sexual and gender minority patients receive specific attention because recommendations may be inconsistent or insufficiently tailored. The main open question is how to convert adult eligibility into sustained vaccination, particularly among underserved groups.
3 papers · 30%
-
HPV Vaccination Policy and Economics
HPV vaccination policy is moving toward broader, school-based access supported by cross-country comparison and economic evaluation. Coverage varies substantially across European programmes, reflecting differences in guidelines, implementation and social context. Return-on-investment analyses frame expanded access as a source of societal and fiscal gains through prevented HPV-related disease and lower health care costs. The remaining challenge is aligning policy design with delivery systems that achieve consistently high coverage.
3 papers · 30%
HPV vaccination is modeled as a fiscal and societal investment, not only a disease-prevention program
The Poland national HPV vaccination program is treated as a macroeconomic and public-finance intervention rather than solely as a means of reducing infection, disease, and mortality 42717549Sep. Whereas the other papers focus on uptake, determinants, delivery, policy implementation, or prevention outcomes, this study projects vaccination’s effects on productivity losses, tax revenues, and healthcare costs over a 100-year horizon. HPV vaccination therefore becomes an instrument for generating societal and fiscal returns, expanding the consequences used to judge the program beyond health outcomes and coverage.
Papers
The 10 papers from the last 6 months that study HPV vaccination directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
HPV Vaccine Hesitancy and Education (4)
- Cognitive and behavioral determinants of HPV vaccination willingness and Behavior among female university students in Karnataka, India. Human vaccines & immunotherapeutics · 8 Oct 2026 PMID 42847160
- Impact of a Culturally Tailored Educational Intervention on Human Papillomavirus Knowledge and Vaccination Intentions Among Women in Saudi Arabia: Quasi-Experimental Study. JMIR public health and surveillance · 16 Sept 2026 PMID 42748422
- A Multimethod Evaluation to Assess Feasibility, Acceptability, and Preliminary Efficacy of HPVVaxFacts, a Tailored Mobile Web App, for Parents With Unvaccinated Children: Pilot 2-Arm Randomized Controlled Trial. JMIR cancer · 9 Sept 2026 PMID 42715554
- Parental awareness, knowledge, and hesitancy toward HPV vaccination for adolescents: A cross-sectional study. Archivos argentinos de pediatria · 16 Jun 2026 PMID 42301822
Adult HPV Vaccine Uptake (3)
- HPV vaccine coverage among adults aged 27-45: Implications for oropharyngeal cancer prevention. Human vaccines & immunotherapeutics · 5 Oct 2026 PMID 42834027
- Trends in HPV vaccination among adults aged 27-45 years in the United States. Human vaccines & immunotherapeutics · 11 Sept 2026 PMID 42723147
- Clinicians' self-reported HPV vaccination recommendations for sexual and gender minority patients. Vaccine · 14 Aug 2026 PMID 42600245
HPV Vaccination Policy and Economics (3)
- Societal and fiscal gains from HPV vaccination in Poland - return on investment from extending access to HPV vaccination. Journal of medical economics · 10 Sept 2026 PMID 42717549
- A Comparative Policy Analysis of HPV Vaccination Guidelines: Actors, Context, Content, and Process Across Eight Countries. Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing · 31 Aug 2026 PMID 42670010
- Human papillomavirus (HPV) Vaccination programmes across European countries: time-harmonized coverage among adolescent females, socioeconomic predictors, and impact on public interest. Vaccine · 20 Aug 2026 PMID 42623713
By study type
Clinical trials (1)
- A Multimethod Evaluation to Assess Feasibility, Acceptability, and Preliminary Efficacy of HPVVaxFacts, a Tailored Mobile Web App, for Parents With Unvaccinated Children: Pilot 2-Arm Randomized Controlled Trial. JMIR cancer · 9 Sept 2026 PMID 42715554
Observational studies and case reports (5)
- Cognitive and behavioral determinants of HPV vaccination willingness and Behavior among female university students in Karnataka, India. Human vaccines & immunotherapeutics · 8 Oct 2026 PMID 42847160
- Trends in HPV vaccination among adults aged 27-45 years in the United States. Human vaccines & immunotherapeutics · 11 Sept 2026 PMID 42723147
- Human papillomavirus (HPV) Vaccination programmes across European countries: time-harmonized coverage among adolescent females, socioeconomic predictors, and impact on public interest. Vaccine · 20 Aug 2026 PMID 42623713
- Clinicians' self-reported HPV vaccination recommendations for sexual and gender minority patients. Vaccine · 14 Aug 2026 PMID 42600245
- Parental awareness, knowledge, and hesitancy toward HPV vaccination for adolescents: A cross-sectional study. Archivos argentinos de pediatria · 16 Jun 2026 PMID 42301822
Human data, design not indexed (4)
- HPV vaccine coverage among adults aged 27-45: Implications for oropharyngeal cancer prevention. Human vaccines & immunotherapeutics · 5 Oct 2026 PMID 42834027
- Impact of a Culturally Tailored Educational Intervention on Human Papillomavirus Knowledge and Vaccination Intentions Among Women in Saudi Arabia: Quasi-Experimental Study. JMIR public health and surveillance · 16 Sept 2026 PMID 42748422
- Societal and fiscal gains from HPV vaccination in Poland - return on investment from extending access to HPV vaccination. Journal of medical economics · 10 Sept 2026 PMID 42717549
- A Comparative Policy Analysis of HPV Vaccination Guidelines: Actors, Context, Content, and Process Across Eight Countries. Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing · 31 Aug 2026 PMID 42670010
Written from 10 PubMed abstracts, each one listed by PMID above. Published: 2026-10-07. Drafted by language models from published abstracts; not medical advice.